By 
Patients with attention-deficit hyperactivity disorder are having trouble filling prescriptions of Adderall and generic versions of the drug amid growing demand and a shortage of the medication, according to manufacturers, retailers and patients.
Camber Clemence, from Fort Myers, Fla., hasn’t been able to get her prescription filled since June, which has forced her to make changes to her life at work and at home. She has dialed back her responsibilities at her marketing job because she has difficulty staying focused. As a parent of two teenagers, she said she struggles to remember scheduled tasks and events.
“It has been kind of a nightmare,” said Clemence, 36 years old. “I can’t get enough done. I feel like I need to take way more breaks than I needed to take before, and I’ve had to shift how I work.”
Teva Pharmaceutical Industries Ltd.
TEVA,
-0.90%,
the largest supplier of Adderall in the U.S., said Friday a labor shortage on the packaging line earlier this year disrupted production of the drug, contributing to delays.
An expanded version of this report appears in WSJ.com.
Top stories from WSJ.com
Saturn Ring Mystery Possibly Solved After Four Centuries of Uncertainty
Welcome to Your Airbnb, the Cleaning Fees Are $143 and You’ll Still Have to Wash the Linens
Comments